One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

Over 6% of American adults are suffering from long COVID, survey finds 05:10. Two new clinical trials to test potential treatments for long COVID are now set to launch, the National Institutes of ...

A drug that has shown promise in HIV patients could be successful in combating symptoms for coronavirus "long haulers.” The trial is set to start this spring and doctors say if it works, it ...

The phase 2 investigational new drug clinical trial tested whether a 15-day course of Paxlovid, an FDA-approved antiviral for acute COVID-19, could also help long COVID patients.

The drugs were identified by an earlier SILC-funded study that, over the past 18 months, examined over 5,400 blood proteins from 1,028 participants with and without long COVID found 13 common ...

An early clinical drug trial taking aim at long COVID fatigue has fallen short of a primary objective to restore normal energy-fueling cell function but still provided encouraging evidence that ...

It’s called COVID long-haul syndrome. A South Florida doctor is overseeing a new study that’s providing hope for “long-haulers.” 7’s Kevin Ozebek was granted exclusive access to the trial.

Researchers are hoping to find out whether more treatments can reduce the risk of long COVID. A large UK-based trial called HEAL-COVID is testing two drugs that target the cardiovascular system in ...

Clinical trials of a new drug aimed at tackling symptoms of long COVID, made by Axcella, show that the drug worked in helping some patients overcome their fatigue.

Waiting for gold-standard clinical trial data means that people with long Covid are suffering needlessly. Doctors should help with off-label drugs.